

EN

Health Care Select Sector SPDR Fund (XLV) Stock Price, Chart, News and AI analysis | Edgen

Back



XLV

Health Care Select Sector SPDR Fund (XLV) Price

XLV Stock Price Chart

XLV Price

Health Care Select Sector SPDR Fund

$154.94

0.66%

$1.03

At close: Dec 18, 16:00:00 GMT-5

$155.22

0.18%

$0.28

Post-market: Dec 18, 20:00:00 GMT-5

Overview Forecast Earnings Dividends Financials

Features

AI Copilot for Stock & Crypto

Price Prediction

Fundraise Tracker

Market Sentiment

Technical Analysis

Crypto Comparison

Trading Strategies

Megabrain Investors Picks

Trading Mindshare

Technical Signals

Resources

Market

Terms of Use Privacy Policy Sitemap

© 2025 Finture Development Limited. All rights reserved

Ask AI About XLV

Ask a question to get started...

No data

No Data Yet

Supported by

1D

+0.92%

5D

+1.06%

30D

+6.56%

6M

+7.56%

YTD

+13.75%

1Y

--

1D

+0.92%

5D

+1.06%

30D

+6.56%

6M

+7.56%

YTD

+13.75%

1Y

--

Related News

iShares Healthcare ETF Gains 12% Driven by Eli Lilly Weight

Dec 19 2025, 05:17

iShares Healthcare ETF Gains 12% Driven by Eli Lilly Weight

The iShares U.S. Healthcare ETF (IYH) has posted a year-to-date return of 12.07%, heavily influenced by its 14.12% allocation to Eli Lilly.

Healthcare Stocks Advance Amid Market Rotation

Dec 12 2025, 13:25

Healthcare Stocks Advance Amid Market Rotation

The healthcare sector posted significant gains, largely driven by positive clinical trial data from Eli Lilly for its obesity drug, retatrutide. This rally occurred within a broader market rotation as investors shifted from technology stocks into value-oriented sectors following a less hawkish update from the Federal Reserve.

S&P 500 High-Flyers Face Diverging 2026 Outlook

Dec 05 2025, 11:32

S&P 500 High-Flyers Face Diverging 2026 Outlook

While a select group of S&P 500 stocks delivered extraordinary gains in 2025, averaging 145% year-to-date, analysis reveals significant vulnerabilities for certain tech leaders. Investors are beginning to differentiate between business models, favoring recurring revenue streams over those dependent on cyclical capital expenditures, signaling a potential market shift.